1. Home
  2. RBKB vs ACOG Comparison

RBKB vs ACOG Comparison

Compare RBKB & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rhinebeck Bancorp Inc.

RBKB

Rhinebeck Bancorp Inc.

HOLD

Current Price

$12.89

Market Cap

200.9M

Sector

Finance

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$8.23

Market Cap

193.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
RBKB
ACOG
Founded
1860
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
200.9M
193.6M
IPO Year
2018
2024

Fundamental Metrics

Financial Performance
Metric
RBKB
ACOG
Price
$12.89
$8.23
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
★ $18.00
AVG Volume (30 Days)
63.1K
★ 94.5K
Earning Date
11-03-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 215.00
41.58
EPS
★ 0.44
N/A
Revenue
$2,984,000.00
★ $10,220,275.00
Revenue This Year
N/A
$153.87
Revenue Next Year
N/A
$85.66
P/E Ratio
$29.43
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$9.41
$4.50
52 Week High
$17.99
$10.14

Technical Indicators

Market Signals
Indicator
RBKB
ACOG
Relative Strength Index (RSI) 51.30 40.60
Support Level $12.58 $8.30
Resistance Level $13.00 $9.48
Average True Range (ATR) 0.18 0.43
MACD 0.00 -0.05
Stochastic Oscillator 45.93 23.64

Price Performance

Historical Comparison
RBKB
ACOG

About RBKB Rhinebeck Bancorp Inc.

Rhinebeck Bancorp Inc is the holding company for Rhinebeck Bank, which is a New York-chartered stock savings bank. It provides a full range of banking and financial services to consumer and commercial customers. Financial services, including investment advisory and financial product sales, are offered through a division of the Bank doing business as Rhinebeck Asset Management. The Bank's primary business activity is accepting deposits from the general public and using those funds together with borrowings, to originate commercial real estate loans (which include multi-family real estate loans and commercial construction loans), commercial business loans and indirect automobile loans, and to purchase one- to four-family residential real estate loans and investment securities.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: